申请人:Keegan S. Kathleen
公开号:US20050245525A1
公开(公告)日:2005-11-03
Aryl- and heteroaryl-substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.
本文披露了芳基和杂环芳基取代的脲类化合物,其可用于治疗与DNA损伤或DNA复制中的损伤相关的疾病和病症。本文还披露了制备这些化合物的方法,以及它们作为治疗剂的用途,例如治疗癌症和其他由DNA复制缺陷、染色体分离或细胞分裂引起的疾病。